The deregulation of both the pro- and anti-apoptotic Bcl-2 proteins plays a crucial role both in the development, growth and expansion of pancreatic cancer and in the resistance to current therapy options [37,55]. This evidence concerns the gene BCL2 and pancreatic neoplasm.